306
Participants
Start Date
February 15, 2021
Primary Completion Date
May 19, 2022
Study Completion Date
October 27, 2022
MiniMed™ 780G System
Subject enrolled in the study will start using the MiniMed™ 780G pump in Auto Mode after a run-in period of two weeks in Manual Mode (with no SmartGuard™ functions). Study phase in Automode will follow a 6 and 12 months follow- up as per standard of care.
CHU Angers, Angers
CHU Besançon, Besançon
APHP Avicenne, Bobigny
CHU Bordeaux (Saint-André), Bordeaux
CH Boulogne-Sur-Mer, Boulogne-sur-Mer
CHU Brest, Brest
HCL Groupement Hospitalier Est, Bron
CHU Caen, Caen
Ch Sud Francilien, Corbeil-Essonnes
CHU Dijon, Dijon
CHRU La Rochelle, La Rochelle
CHU Grenoble, La Tronche
CHU Lille, Lille
CHU Limoges, Limoges
HCL DIAB-eCARE, Lyon
IDNC Chartres, Mainvilliers
APHM Marseille (Hôpital de la Conception), Marseille
APHM Marseille (La Timone), Marseille
GHEF (Centre Hospitalier de Meaux), Meaux
CHU Montpellier (Lapeyronie), Montpellier
CHU Nantes, Nantes
CHU Nice, Nice
CHU Nîmes, Nîmes
APHP Bichat, Paris
APHP Cochin, Paris
Ch Lariboisiere, Paris
CH Perpignan, Perpignan
CH Périgueux, Périgueux
CHU Rennes, Rennes
CHU Strasbourg, Strasbourg
CHU Toulouse (Rangueil), Toulouse
CHU Tours, Tours
Medtronic Diabetes
INDUSTRY